leadership
confidence high
sentiment neutral
materiality 0.40
Salarius Pharma appoints CEO, CSO, CBO with $225k salary and 35% bonus
Decoy Therapeutics Inc.
- Frederick E. Pierce appointed CEO, Dr. Barbara Hibner as CSO, Peter Marschel as CBO effective upon merger closing.
- Each executive receives annual base salary of $225,000 and target annual bonus of 35% of base salary.
- Severance includes $225,000 lump sum plus 9 months COBRA reimbursement if terminated without cause or for good reason.
- Employment agreements incorporate at-will status, restrictive covenants, and eligibility for standard benefits.